TECTONIC THERAPEUTIC, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
TECTONIC THERAPEUTIC, INC. (TECX) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value of $9.64 per share as of 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2022-03-17
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $9.64.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $15.65.
- 2020-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $15.65.
- 2020-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $2.38.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value |
|---|---|
| 2021-12-31 | $9.64 10-K · filed 2022-03-17 |
| 2020-12-31 | $15.65 10-K · filed 2022-03-17 |
| 2020-09-30 | $15.65 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.38 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.56 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.50 10-K · filed 2021-03-18 |
| 2019-09-30 | $0.42 10-Q · filed 2019-11-07 |
| 2019-06-30 | $0.42 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.70 10-Q · filed 2019-05-13 |
| 2018-12-31 | $0.42 10-K · filed 2020-03-16 |
| 2018-09-30 | $0.42 10-Q · filed 2018-11-13 |
| 2018-06-30 | $0.42 10-Q · filed 2018-08-09 |
| 2017-12-31 | $0.42 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |